Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Orexigen Therapeutics, Inc. | 202,650 | reported | 03 Feb 2015 | tx 46+3,165,630−1,480,000 |
| Zosano Pharma Corp | 22,500 | reported | 10 Jun 2021 | tx 9+172,000 |
| Aurinia Pharmaceuticals Inc. | 11,961 | reported | 19 May 2023 | tx 10+103,425−89,005 |
| Regulus Therapeutics Inc. | 0 | reported | 25 Jun 2025 | tx 68+12,934,126−5,215,009 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 571,558 | — | |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 100,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 30,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 160,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 90,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 100,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 1,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 6,500 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 1,312,500 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 249,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 990,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 1,350,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 2,976 | — | deriv |
| 30 Jan 2025 | PURCHASE | Regulus Therapeutics Inc. | 50,000 | 1.09 USD | first after silence |
| 30 Jan 2025 | GRANT_AWARD | Regulus Therapeutics Inc. | 1,350,000 | 0.00 USD | deriv |
| 13 Jan 2025 | SALE | Regulus Therapeutics Inc. | 115,290 | 1.26 USD | |
| 14 Jan 2025 | SALE | Regulus Therapeutics Inc. | 11,764 | 1.26 USD | |
| 09 Jan 2025 | GRANT_AWARD | Regulus Therapeutics Inc. | 218,750 | 1.36 USD | |
| 09 Jan 2025 | GRANT_AWARD | Regulus Therapeutics Inc. | 62,000 | 1.30 USD | |
| 20 May 2024 | GRANT_AWARD | Regulus Therapeutics Inc. | 990,000 | 0.00 USD | deriv |
| 18 Jan 2024 | SALE | Regulus Therapeutics Inc. | 14,580 | 1.19 USD | |
| 12 Jan 2024 | GRANT_AWARD | Regulus Therapeutics Inc. | 30,000 | 0.00 USD | |
| 12 Jan 2024 | GRANT_AWARD | Regulus Therapeutics Inc. | 249,000 | 0.00 USD | deriv |
| 10 Aug 2023 | GRANT_AWARD | Regulus Therapeutics Inc. | 1,312,500 | 0.00 USD | deriv |
| 18 May 2023 | EXERCISE | Aurinia Pharmaceuticals Inc. | 8,733 | — |
5 purchases reported after at least 12 months of silence — most recent on 30 Jan 2025.